IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
(NASDAQ: ICCM) Delayed: 1.95 -0.01 (0.51%)
Previous Close $1.96    52 Week High $ 
Open $1.99    52 Week Low $ 
Day High $2.08    P/E N/A 
Day Low $1.95    EPS $ 
Volume 70,959       

(NASDAQ: ICCM) Delayed: 1.95 -0.01 (0.51%)
Previous Close $1.96    52 Week High $ 
Open $1.99    52 Week Low $ 
Day High $2.08    P/E N/A 
Day Low $1.95    EPS $ 
Volume 70,959